Stakeholders Surprised As French Biosimilar Substitution Changes Tack

France’s Health Ministry And ANSM Agency Deviate From Approach Agreed In Consultation

 
• By Dave Wallace

The latest step towards biosimilar substitution taken by the French authorities has left stakeholders baffled by an unexplained shift in approach, including a change to the specific biologic molecules that have been selected as eligible for substitution.

Change course new direction red paper aeroplane changing tack
France has seen an unexpected change in direction on biosimilar substitution • Source: medrooky / Alamy Stock Photo

More from Biosimilars

More from Products